Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013
- PMID: 26844219
- PMCID: PMC4731480
- DOI: 10.5415/apallergy.2016.6.1.43
Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013
Abstract
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCAR) with high mortality and have a significant public health impact because of high mortality and morbidity.
Objective: To describe data the epidemiological features, etiology, and treatment of retrospectively reviewed data of all patients with SJS and TEN.
Methods: Retrospective study was conducted in patients with SJS and TEN treated from January 1, 2009 to December 31, 2013 in Dr. Hasan Sadikin General Hospital Bandung, Indonesia.
Results: A total of 57 patients were enrolled in the study. Thirty-nine cases of SJS (21 males and 18 females), 7 cases of SJS overlapping TEN (4 males and 3 females), and 11 cases of TEN (5 males and 6 females) were reported. All cases of SJS and TEN were caused by drugs, such as paracetamol (16.56%), carbamazepine (7%), amoxicillin (5.73%), ibuprofen (4.46%), rifampicin (3.18%), and trihexyphenidyl (3.18%). All cases were treated systemically with corticosteroid alone (100%). Seven from 57 patients (12,28%) died; 5 cases developed sepsis and 2 cases developed respiratory failure. The mortality rate was 7.69% in SJS, 0% in SJS/TEN overlap, and 36.36% in TEN.
Conclusion: The role of systemic corticosteroids in SJS and TEN are still controversial, but with a prompt and earlier treatment reduces mortality and improves outcomes of SJS and TEN patients.
Keywords: Corticosteroid Treatment; Stevens-Johnson Syndrome; Toxic Epidermal Necrolysis.
Figures



Similar articles
-
Understanding the Gap Between Acute Complications and Long-Term Sequelae in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Bandung, West Java, Indonesia: Experience from Two Institutions.Clin Cosmet Investig Dermatol. 2025 Apr 21;18:979-988. doi: 10.2147/CCID.S514590. eCollection 2025. Clin Cosmet Investig Dermatol. 2025. PMID: 40292010 Free PMC article.
-
[Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].Arerugi. 2009 May;58(5):537-47. Arerugi. 2009. PMID: 19487835 Japanese.
-
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.Acta Derm Venereol. 2012 Jan;92(1):62-6. doi: 10.2340/00015555-1169. Acta Derm Venereol. 2012. PMID: 21710108
-
Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.Front Med (Lausanne). 2023 Oct 10;10:1232969. doi: 10.3389/fmed.2023.1232969. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37881633 Free PMC article.
-
Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.Burns. 2018 Jun;44(4):807-815. doi: 10.1016/j.burns.2017.10.022. Epub 2018 Apr 4. Burns. 2018. PMID: 29627131 Review.
Cited by
-
Successful Treatment of Methampyrone-Induced Toxic Epidermal Necrolysis with Therapeutic Plasma Exchange.Case Rep Med. 2018 Jul 18;2018:2182604. doi: 10.1155/2018/2182604. eCollection 2018. Case Rep Med. 2018. PMID: 30123277 Free PMC article.
-
Drug hypersensitivity reactions in Asia: regional issues and challenges.Asia Pac Allergy. 2020 Jan 30;10(1):e8. doi: 10.5415/apallergy.2020.10.e8. eCollection 2020 Jan. Asia Pac Allergy. 2020. PMID: 32099830 Free PMC article. Review.
-
Treatment of Severe Dry Eye in Stevens-Johnson Syndrome with Umbilical Cord Serum Eye Drops.Clin Ophthalmol. 2022 Dec 10;16:4089-4095. doi: 10.2147/OPTH.S385078. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36532819 Free PMC article.
-
Cephradine-Induced Toxic Epidermal Necrolysis: A Case Report of Treatment With Etanercept.Cureus. 2022 Dec 18;14(12):e32657. doi: 10.7759/cureus.32657. eCollection 2022 Dec. Cureus. 2022. PMID: 36660513 Free PMC article.
-
Asia Pacific Allergy: it's been five years!Asia Pac Allergy. 2016 Jan;6(1):1-2. doi: 10.5415/apallergy.2016.6.1.1. Epub 2016 Jan 27. Asia Pac Allergy. 2016. PMID: 26844214 Free PMC article. No abstract available.
References
-
- Chung WH, Hung SI. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010;59:325–332. - PubMed
-
- French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006;55:9–16. - PubMed
-
- Valeyrie-Allanore L, Roujeau JC. Epidermal necrolysis (stevens-johnson syndrome and toxic epidermal necrolysis) In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012. pp. 439–448.
-
- Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int. 2007;56:419–425. - PubMed
-
- Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, Roujeau JC, Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol. 2006;126:272–276. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources